MBIO
MBIO
NASDAQ · Biotechnology

Mustang Bio Inc

$0.63
-0.02 (-3.68%)
As of May 16, 2:33 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,549.6% upside
Low Target $6.34
Average Target $10.33
High Target $12.82
Current Price $0.63
Current
$0.63
Target
$10.33
$6.34 $10.33 avg $12.82
Scenario Analysis
Bear Case
$6.34
912.5%
Low target
Base Case
$10.33
+1,549.6%
Avg target
Bull Case
$12.82
+1,947.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$7.00
-91.1% from high
52-Week Low
$0.53
+18.0% from low
Target vs 52W High
$10.33
+47.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%